↓ Skip to main content

PLOS

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Overview of attention for article published in PLOS ONE, May 2012
Altmetric Badge

Mentioned by

policy
2 policy sources
twitter
4 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
132 Dimensions

Readers on

mendeley
333 Mendeley
Title
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
Published in
PLOS ONE, May 2012
DOI 10.1371/journal.pone.0036966
Pubmed ID
Authors

Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen

Abstract

We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 333 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
South Africa 4 1%
Brazil 1 <1%
Unknown 323 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 67 20%
Student > Master 56 17%
Student > Ph. D. Student 54 16%
Student > Postgraduate 22 7%
Student > Bachelor 21 6%
Other 53 16%
Unknown 60 18%
Readers by discipline Count As %
Medicine and Dentistry 124 37%
Agricultural and Biological Sciences 21 6%
Nursing and Health Professions 19 6%
Social Sciences 16 5%
Immunology and Microbiology 13 4%
Other 62 19%
Unknown 78 23%